IRS2 and colorectal carcinoma: As shown in Table 2, we detected an association between IRS-2 gene rs1805097 polymorphism and CRC risk (AA+GA vs. GG: OR, 0.91; 95% CI, 0.84–0.99, P = 0.022, Figure 2).